Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Astrazeneca Plc ADR (NQ: AZN )

66.26 -0.47 (-0.70%)
Streaming Delayed Price Updated: 4:00 PM EDT, Oct 3, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Astrazeneca Plc ADR

< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Amazon's Prime Video Trolls Netflix's Password Crackdown, Tesla Data Leak Exposes Safety Nightmare, Elon Musk's Brain Chip Company Gets FDA Nod For Human Trial: Top Stories For Today
Benzinga 
Via Benzinga
AstraZeneca/Merck's Cancer Drug Combo Shows Positive Results In Endometrial Cancer
Via Benzinga
As Debt Ceiling Talks Wobble, Investors Look To May Fed Minutes, Nvidia Earnings For Direction
(Wednesday market open) Investors seeking distraction from the ticking debt ceiling countdown clock get some this afternoon in the form of Federal Reserve meeting minutes and Nvidia (NASDAQ: NVDA)... 
Via Benzinga
AstraZeneca-Spin Off Entasis Secures FDA Approval For First Pathogen-Targeted Therapy Addressing Acinetobacter
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,000 Today
Via Benzinga
Is AstraZeneca Stock a Buy for Growth Investors?
This drugmaker is among the largest international players in the world. 
Via The Motley Fool
AstraZeneca Unusual Options Activity
Via Benzinga
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Week In Review: LaNova Sells Pre-Clinical ADC To AstraZeneca In $600 Million Deal
LaNova Medicines has sold global rights for a pre-clinical antibody drug conjugate candidate to AstraZeneca for $600 million, including $55 million upfront plus royalties on sales. Meanwhile, Amoytop... 
Via Talk Markets
3 Undervalued Pharma Stocks to Buy for High Total Returns
These are the undervalued pharma stocks to buy as they represent companies investing heavily in research to boost the product pipeline. 
Via InvestorPlace
WHO Recommends New COVID Booster Shots To Target XBB Variants, Despite Slower Uptake
An advisory group for the World Health Organization said the current crop of shots should be updated to target the currently dominant XBB strains for the 
Via Benzinga
What Does AstraZeneca's Debt Look Like?
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $3,700 Today
Via Benzinga
AstraZeneca Plc (AZN) Q1 2023 Earnings Call Transcript
AZN earnings call for the period ending March 31, 2023. 
Via The Motley Fool
DeSantis Vs. Disney, Alibaba Spinoffs Cloud Business, Apple Bans Internal ChatGPT Use: Today's Top Stories
Bloomberg 
Via Benzinga
AstraZeneca's China Executive Seeks Loyalty to "Love the Communist Party" In China
During an event held in the city of Wuxi to commemorate its 30th year in China, AstraZeneca Plc's (NASDAQ: AZN) China president, Wang Lei, said the company will seek to be a patriotic company in China... 
Via Benzinga
The 7 Next Trillion-Dollar Companies to Invest in Now
These are the next trillion-dollar companies to buy thanks to visibility, steady revenue growth and cash flow upside. 
Via InvestorPlace
Apple Thwarts $2B In Fraud Transactions, UBS Takes $17B Hit From 'Hasty Credit Suisse Takeover,' Verizon Streamlines Unlimited Data Plans: Today's Top Stories
Benzinga 
Via Benzinga
One More Quits US Pharma Lobby Group: AstraZeneca Follows Teva, AbbVie Footsteps
AstraZeneca Plc (NASDAQ: AZN) has decided to leave a U.S. drug lobby group, the Pharmaceutical Research and Manufacturers of America (PhRMA), making it the third company to leave the group in the last... 
Via Benzinga
AstraZeneca' Tagrisso/Chemo Combo Therapy Delays Treatment Resistance, Disease Progression In Certain Type Of Advanced Lung Cancer
AstraZeneca Plc (NASDAQ: AZN) has reported topline data 
Via Benzinga
Sanofi, AstraZeneca Release Real-World Data For Respiratory Syncytial Virus Antibody
The race to tap the respiratory syncytial virus (RSV) this season intensifies as Sanofi SA (NASDAQ: SNY) and AstraZeneca Plc (NASDAQ: AZN) have  
Via Benzinga
Sanofi Says Its RSV Shot Significantly Cut Hospitalization Risk In Newborns
The monoclonal antibody shot significantly reduced the risk of hospitalization in babies. 
Via Investor's Business Daily
10 Health Care Stocks With Whale Alerts In Today's Session
Via Benzinga
How To Trade US CPI: The Top 5 Mega-Cap Gainers And Losers Following Last 3 Inflation Reports
Investors are eagerly awaiting the U.S. inflation statistics for April, which will be announced on Wednesday at 8.30 a.m. ET, before the start of trading on Wall Street. 
Via Benzinga
Royalty Pharma Reaffirms FY23 Guidance Post Mixed Q1 Performance
Via Benzinga
The 7 Best Mutual Funds to Invest in for May 2023
With rising uncertainties in the economy and the capital markets, investors have an incentive to consider the best mutual funds. 
Via InvestorPlace
WHO Ends Global Emergency Status for COVID-19 3 Years After Declaration, CDC Director Resigns
The World Health Organization ended the global emergency 
Via Benzinga
GSK: Add This Cheap Chip Play To Your Portfolio
GSK pays a decent quarterly dividend. The latest declared dividend is $0.35 per share, giving GSK a yield of 3.85%. 
Via Talk Markets
3 Low-Volatility Stocks for a Stable Investment Strategy
These are the low-volatility stocks to buy for high total returns as they represent attractively-valued dividend names. 
Via InvestorPlace
FDA Advisory Committee Votes Favoring Restricted Use Of AstraZeneca/Merck's Prostate Cancer Drug
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9
...
36 37 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.